ARTICLE | Clinical News
VimRxyn synthetic hypericin data
September 23, 1996 7:00 AM UTC
VMRX announced that Phase I/II results from Thailand show that 0.05 mg/kg of synthetic hypericin was well tolerated with no toxicity or photosensitivity in the 12 patients with HIV infection enrolled ...